About the company


PLANTING SEEDS OF INNOVATION

Biotechnology is one of the most attractive of any sector today with estimated annual growth in the double-digits. As the biotechnology industry expands globally, millions of additional patients will be gaining access to biologic medicines. This growing demand for treatments, combined with cost constraints and increasingly complex global supply chains, have put pressure on the industry’s ability to manufacture adequate supplies to meet patients’ needs.

WHO WE ARE

Praxis biotech was founded to identify, finance, and develop promising technologies in the life sciences. We here at Praxis biotech regularly chronicle the largest venture capital deals in biotech. We have offered investors direct access to a select portfolio of promising, fast growing and profitable biotech companies listed on stock markets around the world. Thanks to our strong track record over the years and our systematic strategy and clear focus, we have become one of the world’s largest biotech investors.

A TEAM OF PROFESSIONALS

In order to best support rapid growth of its invested companies and products, Praxis biotech has assembled a team of very senior professionals. Our experience suggests that having the best people paired with exciting science is critical to enabling success in development. Experienced investment management team consisting of specialists from the fields of medicine, biochemistry and finance, supported by directors of international stature. Our extended team of advisors has impressive accomplishments of their own. In addition to our board, our advisors and the management team, we have access to extended networks of quality personnel when unique skillsets are needed to drive programs forward.

INVESTING IN FLEXIBLE AND INNOVATIVE BUSINESS PLANS

Praxis biotech invests in companies in the fast growing market of biotechnology and companies with late stage preclinical or early stage clinical therapeutic assets with particular attention to metabolic disease, oncology, and infectious disease. Praxis biotech has the flexibility to deploy part-time or full-time expertise for each investment based on the unique requirements of the project. Partners at Praxis biotech directly invest in our portfolio companies and also have strong connections to other sources of capital and enable rapid follow on financings or entry into the public markets.